Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2014

View Archived Issues

Group develops novel small-molecule polymerase inhibitor to contain measle outbreaks

Researchers develop and test novel oral Shigella challenge model

BMS presents oral pan-Notch inhibitor for cancer

First preclinical results for AMA-0428 as treatment for wet AMD

Lysophospholipid LPA2 receptor ligands for radiation injury synthesized

ADC Therapeutics patents novel antibody-drug conjugates for cancer

Connexios Life Sciences and Boehringer Ingelheim form AMPK activator agreement

Azaya Therapeutics enters collaboration for ATI-1123

Phase II data trace path towards development of LTX-109

NanoViricides reports drug candidates for MERS coronavirus infection

IDH1 gene mutation-specific vaccine developed for treatment of patients with glioma

NN-8555 demonstrates efficacy and safety in phase II Crohn's disease trial

FDA accepts MK-3475 BLA for review in advanced melanoma

Cancer Genetics launches hematological cancer diagnostics

Shire outlines progress of first quarter 2014

C-Cure receives EMA certification of quality data

Japanese researchers disclose novel agents for Alzheimer's disease

Bristol-Myers Squibb discloses novel coagulation factor XIa inhibitors

Mologen files clinical trial applications for phase III trial of anticancer immunostimulant

Roche divulges new TRPA1 antagonists

Janssen submits sNDA to FDA for Olysio in combination with sofosbuvir

Novel compounds for HIV infection designed by Laboratoire Biodim

Favorable safety and efficacy of ITI-007 against acutely exacerbated schizophrenia

AbbVie files for E.U. approval of HCV regimen

Pacira files sNDA for nerve block indication for liposomal bupivacaine

Santhera re-files European MAA for Raxone

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...